These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19214300)

  • 1. Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention.
    Hubacek J; Basran RS; Shrive FM; Shewchuk L; Goodhart DM; Anderson TJ;
    Can J Cardiol; 2009 Feb; 25(2):e42-7. PubMed ID: 19214300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of atorvastatin on interventional therapy in patients with acute myocardial infarction.
    Wang K; Chen L; Liu L; Cui Y; Zhang X; Jiang J
    Minerva Med; 2019 Apr; 110(2):101-106. PubMed ID: 29696937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of troponin T criteria for periprocedural myocardial infarction in patients with acute coronary syndromes.
    Shugman IM; Diu P; Gohil J; Kadappu KK; Leung M; Lo S; Leung DY; Hopkins AP; Juergens CP; French JK
    Am J Cardiol; 2011 Mar; 107(6):863-70. PubMed ID: 21376928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention.
    Gach O; Louis O; Chapelle JP; Vanbelle S; Pierard LA; Legrand V
    Heart Vessels; 2009 Jul; 24(4):267-70. PubMed ID: 19626398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and determinants of myocardial infarction following percutaneous coronary interventions according to the revised Joint Task Force definition of troponin T elevation.
    Alcock RF; Roy P; Adorini K; Lau GT; Kritharides L; Lowe HC; Brieger DB; Freedman SB
    Int J Cardiol; 2010 Apr; 140(1):66-72. PubMed ID: 19131135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention.
    Kizer JR; Muttrej MR; Matthai WH; McConnell J; Nardone H; Sonel AF; Keane MG; Wilensky RL
    Eur Heart J; 2003 Jul; 24(14):1314-22. PubMed ID: 12871688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and myocardial infarction during percutaneous coronary intervention.
    Saleh N; Svane B; Velander M; Nilsson T; Hansson LO; Tornvall P
    J Intern Med; 2004 Jan; 255(1):33-9. PubMed ID: 14687236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.
    Nusca A; Melfi R; Patti G; Sciascio GD
    Future Cardiol; 2010 Sep; 6(5):579-89. PubMed ID: 20932108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention.
    Dautov R; Ybarra LF; Nguyen CM; Gibrat C; Joyal D; Rinfret S
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):E308-E316. PubMed ID: 29481724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
    Celik T; Iyisoy A; Kursaklioglu H; Turhan H; Kilic S; Kose S; Amasyali B; Isik E
    Coron Artery Dis; 2005 Aug; 16(5):293-9. PubMed ID: 16000887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.
    Heeschen C; Hamm CW; Bruemmer J; Simoons ML
    J Am Coll Cardiol; 2000 May; 35(6):1535-42. PubMed ID: 10807457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Urbano-Moral JA; Lopez-Haldon JE; Fernandez M; Mancha F; Sanchez A; Rodriguez-Puras MJ; Villa M; Lopez-Pardo F; Diaz de la Llera L; Valle JI; Martinez A
    Heart; 2012 Aug; 98(15):1153-9. PubMed ID: 22572051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of plasma pentraxin 3 levels for predicting cardiac troponin elevation after percutaneous coronary intervention.
    Wang Z; Sato A; Akiyama D; Kimura T; Tajiri K; Hoshi T; Sakai S; Koike A; Miyauchi T; Aonuma K
    Life Sci; 2014 Jan; 95(1):40-4. PubMed ID: 24333560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome.
    Yun KH; Jeong MH; Oh SK; Rhee SJ; Park EM; Lee EM; Yoo NJ; Kim NH; Ahn YK; Jeong JW
    Heart Vessels; 2009 May; 24(3):175-80. PubMed ID: 19466517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C-reactive protein as an independent marker of prognosis in acute coronary syndrome: comparison with troponin T].
    Möckel M; Heller G; Müller C; Klefisch FR; Riehle M; Searle J; Frei U; Störk T
    Z Kardiol; 2000 Aug; 89(8):658-66. PubMed ID: 11013970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention.
    Veselka J; Procházková S; Duchonová R; Homolová I; Tesar D; Bybee KA
    Heart Vessels; 2006 May; 21(3):146-51. PubMed ID: 16715188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention.
    Ndrepepa G; Colleran R; Braun S; Cassese S; Hieber J; Fusaro M; Kufner S; Ott I; Byrne RA; Husser O; Hengstenberg C; Laugwitz KL; Schunkert H; Kastrati A
    J Am Coll Cardiol; 2016 Nov; 68(21):2259-2268. PubMed ID: 27884243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
    Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
    Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.